Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 3,662 | 2,521 | 1,459 | 1,111 | 352 |
| Cost of Goods | 5,035 | 3,481 | 3,062 | 1,184 | 367 |
| Gross Profit | -1,373 | -960 | -1,604 | -72 | -15 |
| Operating Expenses | 5,234 | 6,836 | 6,966 | 9,397 | 10,241 |
| Operating Income | -6,573 | -7,315 | -8,507 | -9,286 | -9,889 |
| Other Income | -147 | 10,260 | -4,022 | 415 | 1,429 |
| Pre-tax Income | -6,720 | 2,945 | -12,530 | -8,871 | -8,460 |
| Income Tax | N/A | 12 | 6 | -19 | -29 |
| Net Income Continuous | -6,720 | 2,933 | -12,536 | -8,852 | -8,431 |
| Minority Interests | -561 | -1,878 | -1,590 | -2,434 | N/A |
| Net Income | $-6,158 | $4,811 | $-10,946 | $-6,417 | $-8,431 |
| EPS Basic Total Ops | -0.21 | 0.17 | -0.39 | -0.29 | -0.27 |
| EPS Basic Continuous Ops | -0.23 | 0.10 | -0.44 | -0.33 | -0.33 |
| EPS Diluted Total Ops | -0.21 | 0.16 | -0.39 | -0.29 | -0.27 |
| EPS Diluted Continuous Ops | -0.23 | 0.10 | -0.44 | -0.33 | -0.33 |
| EBITDA(a) | $-4,327 | $-5,237 | $-6,753 | $-7,697 | $-9,642 |